| Bioactivity | Arundic acid (ONO-2506) is an astrocyte-modulating agent, which delays the expansion of cerebral infarcts by modulating the activation of astrocytes through inhibition of S-100β synthesis. Arundic acid has the potential for stroke and Alzheimer’s disease research[1][2][3]. | ||||||||||||
| Name | Arundic Acid | ||||||||||||
| CAS | 185517-21-9 | ||||||||||||
| Formula | C11H22O2 | ||||||||||||
| Molar Mass | 186.29 | ||||||||||||
| Appearance | Liquid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Tomoyuki Hasegawa, et al. Process Development of ONO-2506: A Therapeutic Agent for Stroke and Alzheimer's Disease. Org. Process Res. Dev.200372168-171. [2]. Kato H, et al. Arundic acid, an astrocyte-modulating agent, protects dopaminergic neurons against MPTPneurotoxicity in mice. Brain Res. 2004 Dec 24;1030(1):66-73. |
Arundic Acid
CAS: 185517-21-9 F: C11H22O2 W: 186.29
Arundic acid (ONO-2506) is an astrocyte-modulating agent, which delays the expansion of cerebral infarcts by modulating
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.